Sesame Summit 2026 – application open

HealthTech events from 2021-2022


HealthTech Events in 2021

DxPx Conference US

July 27th – 31st 2021 – Virtual

World’s only dedicated partnering conference on diagnostics, precision medicine & research tools.

HIMSS 2021

August 9-12, 2021 – Las Vegas & Virtual

Join peers from around the globe for a unique program with live and on-demand content from big-name visionary speakers and healthcare experts. Participate in sessions, revolutionized networking, demos and more from home.

Future Health Virtual Summit 2021

September 22-23, 2021, Dublin & Virtual

The Future Health Summit is the global gathering for healthcare in Ireland. With 500+ delegates, 50+ Exhibitors and 80% senior level audience.

The MedTech Conference

September 27-30, 2021, Washington & Virtual

Featuring world‑class plenary speakers, cross‑cutting educational programming, valuable networking and business development opportunities, The MedTech Conference is a must‑attend event for the industry’s prominent and most promising companies.

HETT Show

September 28-29, 2021, London

Ushering in a new era of Digital Health Transformation. Delivering better patient experience and operational efficiencies through education and networking opportunities. One connection at a time!

Pharma Europe 2021

October 11-22, 2021, Virtual

Join thousands of your peers at the world’s gathering for pharma pioneers and health innovators – Reuters Events Pharma Europe (formerly eyeforpharma Barcelona) – the biggest, most senior and cross-functional commercial pharma event.

Intelligent Health

October 12, 2021, Amsterdam & Virtual

Now co-located with World Summit AI and TMinus30!
Connecting 200,000 clinicians, technologists and C-suite executives to create a future where AI will revolutionise health

HLTH 2021

October 17-20, 2021, Boston & Virtual

HLTH (health) is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation.

Frontiers Health

November 11-12, 2021, TBA

Frontiers Health emerged as one of the premier global digital health innovation events, with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments, and ecosystem development.

MEDICA 2021

November 15-18, 2021, Düsseldorf

The world of medicine meets at MEDICA 2021. A must for anyone who wants to experience tomorrow’s healthcare market live.

DxPx Conference 2021

November 16-20, 2021, Dusseldorf & Virtual

Where innovative growth companies, investors and industry partners discuss financing, licensing and M&A partnerships.

GIANT Health Event

November 30- December 1, 2021, London

The GIANT (Global Innovation and New Technology) Health Event is an unmissable innovation festival with over 25 conferences, 450 speakers, immersive workshops, and Beanstalks (a global startup competition for prizes). Our vision is to improve the health and well-being of people around the world, by promoting healthcare innovation and supporting health-tech entrepreneurs.

Health Tech Events in 2022

World Health Care Congress 2022

TBA 2022, TBA

IMSH 2022

TBA January, 2022, Los Angeles & Virtual

More information coming soon!

CES 2022

January 5-8, 2022, Las Vegas & Virtual

CES®, the world’s most influential technology event, will return to Las Vegas, Nevada — and also digitally — for CES 2022, giving a global audience access to major brands and startups, as well as the industry’s most influential leaders and advocates.

LSX World Congress

February 8-9, 2022, London

For 7 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making.

Digital Healthcare Innovation Summit (DHIS)

TBA Spring, 2022

The Digital Healthcare Innovation Summit (DHIS) is an unparalleled annual gathering of the leading innovators, investors, payers, providers and policymakers who are driving the digital health revolution.

DIA Europe 2022

March 29-31, 2022, Brussels & Virtual

Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job, your participation will accelerate your growth and your organization’s performance in the development ecosystem.

ViVE

March 6-9, 2022, Miami Beach

ViVE provides a fresh, curated education and networking experience for digital health leaders, disruptors and influencers.

The Festival of Biologics

March 9-11, 2022, San Diego

The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market.

World Medical Innovation Forum

May 2-4, 2022, Boston

How will gene and cell therapy change health care? Join CEOs, industry leaders, and Harvard’s top medical faculty to assess the future of medicine and the specific actions needed to realize the promise of emerging research for patients everywhere.


Not seeing your favorite HealthTech event here?

you might also like

Fundraising 5 hours ago

London-based AI laboratory Ineffable Intelligence has emerged from stealth with a $1.1 billion seed round at a $5.1 billion post-money valuation, the company confirmed on 27 April 2026. The financing is the largest seed round ever raised by a European company and one of the largest first-money-in rounds in the global history of artificial intelligence. The round was co-led by Sequoia Capital and Lightspeed Venture Partners. Participating investors included Nvidia, DST Global, Index Ventures, Google, and the UK Sovereign AI Fund, the British government’s recently established vehicle for backing strategic AI capacity on home soil. A bet on a different path to general intelligence Ineffable Intelligence was founded in 2025 by David Silver, the former Vice President of Reinforcement Learning at Google DeepMind and the principal architect of AlphaGo, AlphaZero and AlphaStar. He is joined by three further DeepMind alumni: Wojciech Czarnecki, Lasse Espeholt and Junhyuk Oh. All four have spent the past decade at the frontier of reinforcement learning research, the discipline behind some of the most consequential demonstrations of machine learning over the past ten years. The company describes its objective as building a “superlearner” — an AI system capable of acquiring knowledge directly from its own experience rather than from human-generated text or imagery. “Our mission is to make first contact with superintelligence,” Silver said in a statement accompanying the launch. “We are creating a superlearner that discovers all knowledge from its own experience, from elementary motor skills through to profound intellectual breakthroughs.” The framing is a deliberate departure from the dominant industry trajectory. Most leading AI laboratories, including OpenAI, Anthropic and Google DeepMind itself, have built large language models trained primarily on the corpus of the internet, then refined that training with human feedback. Ineffable’s wager is that the marginal returns on scaling text-based pretraining are diminishing and that the next leap in capability will come from agents that learn endlessly from the consequences of their own actions, in much the same way AlphaZero learnt the game of Go without studying any human matches. Why $1.1 billion at seed The size of the round is unusual even by the inflated standards of the 2026 AI capital cycle. Two factors appear to explain it. First, frontier reinforcement learning at the scale Ineffable describes is computationally extraordinarily expensive: the company will need to operate vast simulation environments and train very large models against them, an undertaking that consumes capital at a rate closer to physical R&D than to traditional software. Second, the round signals a strategic move by Europe’s investor and policy ecosystems to retain the most ambitious AI researchers on the continent. The presence of the UK Sovereign AI Fund alongside Sequoia, Lightspeed and Nvidia is the clearest expression of that intent. The British government has publicly framed the investment as a bet on breakthrough AI that “can discover new knowledge”, positioning the country as a willing co-investor in domestic frontier laboratories. For Ineffable, the implication is access not only to capital but to compute, regulatory engagement and the still-resilient academic talent base around UCL, Oxford, Cambridge and Imperial. Founder pledge of historic scale Alongside the funding announcement, Silver disclosed that he is committing 100 per cent of any personal proceeds from his Ineffable equity to charity via the Founders Pledge network — described by the organisation as the largest pledge in its history. At the round’s $5.1 billion valuation, that commitment could ultimately exceed several billion dollars if the company succeeds. It is a meaningful gesture in a sector where the reputational stakes around concentrated AI wealth are escalating, and one likely to be referenced in subsequent founder-led commitments. Implications for the European AI landscape Ineffable’s emergence reshapes the European AI map in three concrete ways. It establishes London as the home of the continent’s largest-ever seed-stage company, complicating Paris’s recent narrative of frontier-AI primacy after Mistral’s earlier rounds. It validates a thesis — that reinforcement learning, not transformer scaling, is the next frontier — that has lately been losing capital share to language-model incumbents. And it confirms that the UK government is now willing to act as a balance-sheet co-investor in domestic AI laboratories, a posture much closer to the French model than to the predominantly grant-based regimes elsewhere in Europe. The execution risk is non-trivial. Reinforcement learning at frontier scale has historically required years of careful environment design before producing competitive systems, and Ineffable’s “first contact” framing sets a high bar against which it will be judged. But for now, with a billion dollars on the balance sheet, four of the discipline’s most accomplished researchers in the founding team and a sovereign co-investor at its back, Ineffable Intelligence is the most heavily resourced new entrant in the European AI cycle. Sesamers covers European fundraising rounds across deeptech, fintech and AI. Source: tech.eu.

Fundraising 5 days ago

Belfast's Cloudsmith has raised $72M Series C led by TCV, with Insight Partners participating, to expand its artifact management platform and secure the AI-era software supply chain.

Fundraising 5 days ago

Berlin’s VREY has raised €3.3M seed led by Rubio Impact Ventures to roll out rooftop solar software for Germany’s multi-family buildings.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.